In the adult spinal cord, immunocytochemical staining for NT75 is concentrated in nerve terminals in the superficial laminae of the dorsal horn. Deeper laminae of the dorsal horn contain moderate immunocytochemical labeling, but the ventral horn is only sparsely stained. The origin of spinal nerve terminals containing NT75 was investigated with lesion techniques, colchicine treatment, and retrograde tracing in combination with immunocytochemical staining. Primary afferent neurons express NT75 immunoreactivity and account for most of the dense staining in the superficial dorsal horn and part of the labeling in the deeper laminae. It was found that corticospinal and virtually all brainstem neurons with descending projections to the spinal cord also express NT75 immunoreactivity, including those terminating in the ventral horn. Colchicine treatment of the spinal cord also resulted in NT75 staining in most, if not all, spinal neurons. It appears that neurons in all three major sources of spinal afferents (primary sensory, descending, and intrinsic systems) can express NT75 immunoreactivity, but that some neurons normally contain higher levels of the protein in their nerve terminals. Previous analysis of developing spinal cord has shown widespread, dense NT75 labeling throughout the spinal gray in the early postnatal period, which later becomes restricted to the adult pattern. These studies support the hypothesis that many spinal pathways express high levels of NT75 immunoreactivity during development, but that only certain pathways maintain high levels in the adult.

Previous studies of the nerve terminal protein NT75 in the developing spinal cord have suggested an association between the appearance of NT75 immunoreactivity and the process of synaptogenesis. To examine the time course of NT75 expression further, the current study compared the localization of NT75 and the synaptic vesicle protein synaptophysin in the adult and developing rat cerebellum and in cerebellar tissue cultures. In the adult cerebellum, dense NT75 staining is confined to the molecular layer, where it is associated with parallel fiber endings of cerebellar granule cells. During development, NT75 immunoreactivity is first detectable in the cerebellar cortex as a dense band of staining in the deepest portion of the molecular layer at postnatal day 10. The stained zone expands to occupy a progressively greater portion of the molecular layer until about postnatal day 20. Synaptophysin staining occurs in granule cell processes earlier than NT75 and is found throughout the molecular layer by postnatal day 7. Quantitatively, rapid increases in both NT75 and synaptophysin occur in the first three postnatal weeks, with NT75 activity reaching levels exceeding the adult value by 50% over postnatal days 20 through 30, whereas synaptophysin plateaus at near adult levels by postnatal day 20. In cerebellar cultures, NT75 staining in neurites develops over several days, increasing coincidentally with development of synaptic contacts, whereas synaptophysin staining is already present in most neurites after only 1 day in vitro. The results indicate that NT75 expression in developing cerebellar granule cell nerve terminals is closely associated with the appearance of mature nerve terminals, suggesting that the protein may have a role in the formation/stabilization of the synaptic ending or in the mechanisms of synaptic transmission.

In the adult spinal cord, the neuron‐specific protein NT75 is located in nerve terminals synapsing in the superficial laminae of the dorsal horn. The present study examines the occurrence of NT75 in the developing rat spinal cord. NT75 immunoreactivity is detectable in primary afferent axons at the dorsal root entry zone on embryonic day 15. Subsequently, staining of presumptive nerve terminals appears in the deeper laminae of the dorsal horn, expanding into the superficial laminae during the first postnatal week. NT75 staining also appears in developing corticospinal tract axons in the brainstem at birth, and at lumbosacral levels by postnatal day 5. As NT75‐positive nerve terminals approach the adult distribution, staining of primary afferent and corticospinal axons decreases, becoming undetectable by postnatal day 30. Dense transient staining of presumed nerve terminals in the ventral horn is also apparent during early postnatal development. Quantitative analysis of developing spinal cord shows a low level of NT75 immunoreactivity at birth. NT75 activity then increases substantially, reaching values by the third and fourth postnatal weeks up to 2.5 times that seen in adults. The occurrence of NT75 immunoreactivity correlates with the reported time course of synaptic development in the spinal cord. In addition, the results suggest that NT75 immunoreactivity is maintained at high levels in the nerve terminals of certain neural pathways into adulthood, whereas in other systems NT75 immunoreactivity may be detectable only during development.

A monoclonal antibody, designated S-7B8, recognizes a protein antigen localized to highly selected populations of nerve terminals in spinal cord and brain. The antibody produces dense immunocytochemical staining of primary afferent endings that synapse in superficial laminae of the spinal cord dorsal horn. Electron microscopy shows staining to be localized in nerve terminals where reaction product is associated primarily with spherical vesicles. In brain, S-7B8 immunoreactivity occurs in nerve terminals in sensory relay nuclei, most thalamic nuclei, and other selected areas, including the cerebellar molecular layer, the substantia nigra, the globus pallidus, and certain synaptic layers of the hippocampus and dentate gyrus. Endocrine glands and other tissues do not exhibit S-7B8 immunoreactivity. Although the antibody localizes to certain populations of nerve terminals that may use excitatory amino acid neurotransmitters, the distribution of S-7B8 immunoreactivity in the CNS does not correspond to that of any previously identified nerve terminal protein. Experiments to characterize the S-7B8 antigen indicate it may be an integral membrane component since extraction of synaptosomes with alkaline pH or high ionic strength does not release the antigen from the membranes. To identify the molecular weight of the S-7B8 antigen, synaptosomal membranes were solubilized in CHAPS and sequentially chromatographed on hydroxylapatite and then on DEAE anion-exchange resin to produce enriched fractions. When enriched fractions were separated on SDS-PAGE and Western blotted, the S-7B8 antibody specifically stained a protein migrating at 75,000 Da. This protein has been designated NT75. Preliminary studies of developing pathways show that the appearance of S-7B8 immunoreactivity in growing nerve endings corresponds closely to the time when synaptic connections are formed. Thus, the NT75 protein recognized by the S-7B8 antibody may have a role in the development and maintenance of specific synaptic endings.

Three monoclonal antibodies against rat brain synaptosomes, produced by conventional hybridoma techniques, were screened for their ability to undergo uptake and axonal transport in vivo. Injections of ascitic fluid or of purified immunoglobulin G (IgG) were made into the vitreal chamber of the eye in anesthetized rats to test for anterograde transport in retinal afferents to the contralateral superior colliculus. Retrograde transport by facial nucleus motoneurons was evaluated after injections of antibody into the mystatial vibrissal skin and musculature. Transported immunoglobulins were localized in tissue sections using a modification of the peroxidase-antiperoxidase technique. One monoclonal antibody, S-2C10, was found to undergo anterograde transport in retinal ganglion cells and retrograde axonal transport in facial motoneurons. Transported immunoglobulins were detectable even after injections of dilute antibody solution (0.01-0.05% IgG), and the uptake-transport process for this antibody appeared saturable. Two other antibodies tested, S-4E9 and S-1G10, exhibited the ability to undergo retrograde transport, but only after injections at relatively high antibody concentrations (greater than or equal to 1.0% IgG). Neither of these antibodies was shown to undergo anterograde transport. Following retrograde transport in motoneurons, the S-2C10 antibody was localized in neuronal perikarya, proximal dendrites, and the adjacent neuropil of the facial motor nucleus. In contrast, the S-4E9 and S-1G10 antibodies were localized in punctate granules within neuronal cell somata following transport. The findings suggest that the uptake-transport process for the S-2C10 antibody is mediated by adsorptive endocytosis following binding of the antibody to a plasma membrane component (or components) present in somadendritic and nerve terminal membranes.(ABSTRACT TRUNCATED AT 250 WORDS)

Experiments examined the feasibility of using the axonal transport of antibodies as a possible means to characterize nerve membrane composition and the fate of internalized macromolecules. Polyspecific antibodies were generated in rabbits against rat brain synaptosomal and microsomal subcellular fractions and against wheat germ agglutinin-binding proteins isolated by lectin affinity chromatography. Antisera were injected into the vitreal chamber of the eye and into the facial musculature of anesthetized rats to test, respectively, for anterograde transport in retinotectal neurons and for retrograde transport in facial motoneurons. Control injections of preimmune serum were made into the opposite side. After survival for 4-168 h, animals were perfused and the axonally transported rabbit immunoglobulins detected in frozen sections of the brainstem using a modified peroxidase-antiperoxidase immunocytochemical procedure. Antisera against all 3 classes of neuronal antigens contained antibodies that underwent retrograde axonal transport. No evidence of anterograde transport was seen. Neurons containing retrogradely transported immunoglobulins exhibited punctate as well as diffuse staining of the cytoplasm and proximal dendrites, exclusive of the nucleus. Following retrograde transport of antibodies to the synaptosomal fraction, staining of the neuropil around motoneurons was also observed, suggesting transcellular transport of these antibodies. Concentrations of injected antibodies as low as 1% of whole antiserum led to detectable retrograde transport. Increasing concentrations of antibodies above the amount in whole antiserum did not increase the intensity of staining in retrogradely labeled neurons, suggesting saturation. The findings support the view that antibodies to neural membranes are taken up and transported by binding to specific sites on nerve terminals.(ABSTRACT TRUNCATED AT 250 WORDS)

A double labeling technique employing retrograde labeling of vagal neurons with horseradish peroxidase from injections into the stomach wall and immunocytochemistry for dopamine-β-hydroxylase revealed catecholaminergic neurons in the medulla oblongata which project into the abdomen. The great majority of such neurons were located in the dorsal motor nucleus of the vagus, particularly in its rostral third.

Axonal and transneuronal transport of the plant lectins wheat germ agglutinin (WGA),Pisum sativum agglutinin (PSA),Lens culinaris agglutinin (LCA), soybean agglutinin (SBA), peanut agglutinin (PNA), concanavalin A agglutinin (Con A), and Ulex europeus agglutinin (UEA) were examined and compared using an immunocytochemical staining method. WGA, which binds to N-acetylglucosamine and sialic acid carbohydrate residues, and the 3 mannose binding lectins (Con A, PSA and LCA) were found to undergo retrograde transport to the facial nucleus after injection into the facial muscles, and anterograde transport to the optic tectum after injection in the vitreous, and to the spinal trigeminal nucleus caudalis after injection into the mystatial vibrassae. SBA showed a slight tendency to be transported retrogradely, but not in the anterograde direction, whereas UEA and PNA were not axonally transported in any of these systems. All lectins which were transported in the anterograde direction labeled neuronal somata in their respective terminal fields indicating that transneuronal transport had taken place. Axonal and transneuronal transport of the lectins appears to be dependent upon their respective carbohydrate affinities. Transneuronal transport which can be demonstrated for certain lectins indicates that mechanisms exist whereby neurons exchange large molecules which could be involved in mediating trophic and other influences on target cells.

This report describes the distribution of noradrenergic cells in the brainstem and the pattern of terminal varicosisties in the spinal cord of monkey using the immunocytochemical localization of dopamine-β-hydroxylase (DBH). Using two separate and equally reliable techniques, retrograde transport of the antibody to DBH and a double-labeling method, the cells of origin of noradrenergic fibers in the spinal cord have been identified. The results of these studies indicate that 79% of all noradrenergic cells with axons projecting to the spinal cord are located in the nucleus subcoeruleus and nucleus locus coeruleus. Other pontine noradrenergic cell groups contrbute the remainder of the fibers to the cord. No medullary cells contribute to the noradrenergic innervation of the spinal cord.

A mixture of tritiated proline and fucose was injected into the endolymph of one of the membranous labyrinths of each of 5 white king pigeons (Columba livia). The membranous labyrinth was resealed and the animals were allowed to survive for 15 days. Brains and upper parts of the spinal cords were sectioned and processed by standard autoradiographic procedures. Clear labeling was noted in structures usually associated with both the ascending auditory pathways and the ascending and descending vestibular pathways. Vestibular structures ipsilateral to the injected labyrinth which contained heavy labeling were Scarpa's ganglion and all 6 vestibular nuclei. No labeling was noted in the contralateral Scarpa's ganglion and sparce, if any, labeling was noted in the contralateral vestibular nuclei. Contralateral structures associated with ascending vestibulo-ocular pathways which contained heavy labeling were the medial longitudinal fasciculus, abducens nucleus, trochlear nucleus, and two parts of the oculomotor nucleus--the dorsolateral part and the ventromedial part. Less heavily labeled ipsilateral vestibulo-ocular-related structures included the medial longitudinal fasciculus, abducens nucleus and the ventrolateral edge of the trochlear nucleus. The dorsomedial part of the oculomotor nucleus was heavily labeled on the side ipsilateral to the injected labyrinth. Slight, if any, labeling was noted in either the ipsilateral or contralateral brachium conjunctivum or regions corresponding to the mammalian ascending tract of Deiters. The medullary core of most folia but primarily the medullary core and granular areas of folia IX and X of the cerebellum were labeled.(ABSTRACT TRUNCATED AT 250 WORDS)

The localization of serotonergic, various peptidergic and possibly cholinergic neurons in the medullary raphe nuclei that project to the lumbosacral spinal cord have been studied using a retrograde transport method combined with immunocytochemical and histochemical techniques. Spinally projecting neurons stained for serotonin-like, substance P-like, enkephalin-like and thyrotropin-releasing hormone-like immunoreactivity and for the histochemical marker acetylcholinesterase were all observed in each of the raphe nuclei of the medulla, as well as in the adjacent ventrolateral reticular formation. The similar distributions of the descending serotonergic and peptidergic neurons in the raphe nuclei as well as quantitative data on their relative numbers suggest that a large fraction of raphe-spinal neurons contain serotonin co-existing with one or more peptides in the same cell.

Noradrenergic terminals were identified in the spinal cord of rats by immunocytochemical staining for dopamine-β-hydroxylase. Although immunoreactive fibers and terminals were observed throughout the spinal grey matter, heavier accumulations of terminal labeling were observed in the marginal layer of the dorsal horn, in the ventral horn among motoneurons, and in the autonomic lateral cell columns of the thoracic and sacral spinal cord. Two specific retrograde transport techniques were employed to identify the origins of these noradrenergic terminations in the spinal cord. Cells of origin were observed in the locus coeruleus, the subcoeruleus, the medial and lateral parabrachial, and the Ko¨lliker-Fuse nuclei, as well as adjacent to the superior olivary nucleus. These regions correspond to the A5–A7 cell groups of the pons. No spinally projecting noradrenergic cells were ever observed in the medulla. It was concluded that pontine noradrenergic cell groups are the sole source of noradrenergic terminals in the spinal cord.

The localization of serotonergic and various peptidergic neurons in the medullary raphe nuclei that project to the lumbosacral spinal cord have been studied using a retrograde transport method combined with immunocytochemistry. Spinally projecting neurons stained for serotonin-like, substance P-like, enkephalin-like and thyrotropin-releasing hormone-like immunoreactivity were all observed in the raphe nuclei of the medulla, as well as in the adjacent ventrolateral reticular formation. The distribution of the descending serotonergic and peptidergic neurons in the raphe nuclei as well as quantitative data on their relative numbers suggest that a large fraction of raphe-spinal neurons contain serotonin co-existing with one or more peptides in the same cell.

A newly developed technique employing the retrograde transport of horseradish peroxidase combined with immunocytochemistry is used to identify the cells of origin of descending spinal pathways and their putative neurotransmitters. With this technique the brainstem origins of descending serotonergic (5HT) pathways to the lumbar spinal cord have been determined in the monkey. Numerous 5HT stained neurons are found in the nucleus raphe obscurus and raphe magnus and in the adjacent reticular formation projecting to the lumbar spinal cord. The nucleus raphe pallidus contains relatively fewer descending 5HT neurons. In addition to the spinally projecting neurons containing 5HT, large multipolar shaped neurons within the raphe nuclei were found to project to the spinal cord, but these do not stain for 5HT immunoreactivity. These findings indicate that the raphe nuclear complex provides both serotonergic and non-serotonergic inputs to the spinal cord. The advantages and uses of the present double labeling method for localizing other neurotransmitter substances in identified neuronal pathways are discussed.

Publisher Summary This chapter discusses the organization of descending serotonergic projections to the spinal cord. The indolamine serotonin is believed to have important neurotransmitter and/or neuroregulatory roles in the descending pathways influencing various somatosensory, motor, and autonomic functions within the spinal cord. The autonomic preganglionic neurons of the thoracic spinal cord, as well as the motoneurons of the ventral horn, are also under the influence of descending serotonergic cell groups. Cells in these various motoneuron pools can be inhibited and/or excited by iontophoretic application of serotonin or by electrical stimulation of the descending serotonergic pathways. In recent years, the introduction of immunocytochemistry to neurobiology has provided a very sensitive method for studying the organization of descending serotonergic pathways. In contrast to the previously employed histofluorescence methods with which rapid photodecom-position of the yellow fluorescing cells and terminals was a constant problem, the peroxidase-antiperoxidase (PAP) immunochemical method results in a relatively permanent marker for 5-HT neurons and terminals.